Highest-materiality recent filing
Director Lewis Titterton retires; Anthony Bowers appointed to ParkerVision board
Lewis Titterton resigned as director and from Audit/Compensation committees on May 15, 2026, citing retirement, no disagreement.
ParkerVision reports Q1 net loss $1.6M; Qualcomm appeal oral arguments June 1
Net loss of $1.6M ($0.01/share) for Q1 2026 vs. $3.8M loss a year ago; decrease driven by $2.1M fair value adjustment on contingent obligations.
ParkerVision extends CEO and CFO stock option expiration to 2029; records $360K non-cash charge
CEO Jeffrey Parker's 2,660,000 options and CFO Cynthia French's 870,550 options extended from Aug 7, 2026 to Aug 7, 2029.
ParkerVision reports $7.4M net loss; Qualcomm appeal expedited, MediaTek trial postponed
Net loss of $7.4M ($0.06/share) vs. $14.5M loss in 2024; improvement driven by $0.6M gain on contingent payment obligations.
ParkerVision exchanges $688K in notes+interest for 3.28M shares at $0.21/share
Aggregate outstanding principal of $675,000 and accrued interest of $13,200 exchanged for 3,277,099 common shares.
CEO Jeffrey Parker receives option for up to 8M shares at $0.24; CFO Cynthia French receives option for 500K shares at same price.
ParkerVision closes $3.46M registered direct offering of 16.5M shares at $0.21/share
Sold 16,481,579 shares at $0.21 each for gross proceeds of ~$3.46M to accredited and institutional investors.
ParkerVision Raises $3.46M in Registered Direct Offering of 16.48M Shares
Sold 16,481,579 shares at $0.21 per share, generating ~$3.46M in aggregate proceeds.
ParkerVision raises $1M via stock sale to director Titterton at $0.21/share
Director Lewis Titterton Jr. agrees to purchase 4,761,905 shares at $0.21/share for an aggregate $1,000,000.
ParkerVision sells $1M common stock to director at $0.21/share
Closed sale of 4,761,905 shares to independent director Lewis H. Titterton, Jr. for $1M gross proceeds.
ParkerVision reports Q3 2025 net loss of $2.0M; updates on Qualcomm appeal and upcoming trials
Net loss $2.0M ($0.02/share) in Q3 2025 vs $10.8M ($0.12/share) in Q3 2024; improvement from lower fair-value loss on contingent payment obligations.
Shareholders elected Paul A. Rosenbaum and Robert G. Sterne as Class III directors with over 19.3 million votes for each.
ParkerVision Q2 net loss $1.6M; patent litigation updates on Qualcomm, Realtek, MediaTek
Net loss $1.6M for Q2 2025 ($0.01/share) vs $0.3M loss in Q2 2024; H1 2025 loss $5.4M ($0.05/share).
ParkerVision board approves increase in equity plan share reserve from 30M to 45M shares
Board amended 2019 Long-Term Incentive Plan on June 10, 2025, raising share reserve from 30M to 45M.
ParkerVision Q1 net loss widens to $3.8M; litigation updates on Qualcomm & Texas cases
Net loss of $3.8M ($0.03/share) vs $0.7M loss in Q3 2024; increase largely due to $2.5M non-cash fair value adjustment.
ParkerVision board member resigns; CEO and CFO get salary increases and option extension
Director Sanford Litvack resigned from board and committees effective April 15, 2025, with no disagreement.
ParkerVision reports 2024 net loss of $14.5M; patent case against Qualcomm remanded for trial
Net loss of $14.5M ($0.16 loss per share) vs net income of $9.5M ($0.11 EPS) in 2023.
ParkerVision launches "Against the Giants" video series on Qualcomm litigation
First episode of four-part series now live on @Against_Giants on X and Instagram.
ParkerVision awards CEO $350K, CFO $100K one-time bonuses for strategic contributions
CEO Jeffrey Parker received $350K and CFO Cynthia French $100K in one-time discretionary cash bonuses on Jan 15, 2025.
ParkerVision raises $5M through private placement of 10M shares and 2M warrants at $0.50/share
Raised $5M aggregate proceeds from sale of 10,000,000 shares and 2,000,000 warrants at $0.50/share.
ParkerVision appoints Frazier & Deeter as new independent auditor for FY 2024
Audit committee approved appointment of Frazier & Deeter on Nov 12; finalized Dec 16-17, 2024.
ParkerVision reports Q3 net loss of $10.8M; CAFC rules favorably in Qualcomm case
Net loss of $10.8M ($0.12/share) for Q3 2024 vs $3.9M loss in Q3 2023.
MSL, P.A. notified ParkerVision on Nov 1, 2024 that it will cease as auditor after completing Q3 2024 review due to its merger with Forvis Mazars, LLP.
ParkerVision auditor MSL absorbed by Forvis Mazars; successor search started
Auditor MSL, P.A. will cease after completing Q3 2024 review; all MSL staff join Forvis Mazars.
Shareholders authorize increase in Parkervision common stock to 225M shares
Approved amendment raising authorized common stock from 175M to 225M; effective Oct 30, 2024.
ParkerVision wins CAFC appeal; Qualcomm patent case remanded for trial in Florida
CAFC reversed district court's Daubert exclusion of expert testimony, reinstating infringement claims.
ParkerVision Q2 net loss $0.3M vs year-ago net income; patent litigation updates
Net loss of $0.3M ($0.00 per share) for Q2 2024 vs net income of $1.4M ($0.02) in Q2 2023.
Extended $500K 2019 note maturity to Dec 1, 2024; auto-renewable to July 2025, then up to ten 1-yr extensions at 7.5% interest.
ParkerVision extends three convertible notes totaling $350k to Dec 1, 2024
$150k note from June 2019 extended from June 7 to Dec 1, 2024; conversion price $0.10 unchanged.
On May 19, 2026, the Board unanimously appointed Anthony Bowers to fill the director vacancy created by Mr. Titterton’s resignation.
On May 15, 2026, Mr. Lewis Titterton resigned from the Board of Directors (the “Board”) of ParkerVision, Inc. (the "Company"), and from the Audit and Compensation Committees on which he served.
On April 15, 2025, Mr. Sanford Litvack resigned from our Board of Directors, and from the Audit and Compensation Committees on which he served.
Max materiality 0.85 · Median 0.55 · Most common event other_material